Table 5.
Outcome for patients with vulnerable or stable plaques according to filter-based embolic protection device used
| FilterWire 1 | Vulnerable plaque (n = 66) | Stable plaque (n = 55) | p-value |
|---|---|---|---|
| Flow impairment | 8 (12.1%) | 6 (10.9%) | 1* |
| Ischemic neurological events | 3 (4.5%) | 2 (3.6%) | 1* |
| New white lesions on DWI | 27 (40.9%) | 11 (20.0%) | 0.02** |
| Spider 2 | Vulnerable plaque (n = 23) | Stable plaque (n = 14) | p-value |
| Flow impairment | 1 (4.3%) | 0 (0%) | 1* |
| Ischemic neurological events | 1 (4.3%) | 0 (0%) | 1* |
| New white lesions on DWI3 | 10 (43.5%) | 4 (28.6%) | 0.36** |
1FilterWire EZ™.
2Spider FX™.
3DWI, diffusion-weighted magnetic resonance imaging.
*Fisher’s exact test; **Pearson’s Chi-squared test.